New biological aspects of Chromogranin A-derived peptides: Focus on vasostatins

Comparative Biochemistry and Physiology - A Molecular and Integrative Physiology

Volumn 147, Issue 1, 2007, Pages 11-18

  Tota, Bruno ^a   Quintieri, Anna Maria ^a   Di Felice, Valentina ^b   Cerra, Maria Carmela ^a  

^a UNIVERSITY OF CALABRIA   (Italy)

^b UNIVERSITY OF PALERMO   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

CHROMOGRANIN A; PARATHYROID HORMONE; PEPTIDE FRAGMENT; UNCLASSIFIED DRUG; VASOSTATIN 1; VASOSTATIN 2;

AMINO ACID SEQUENCE; AMINO TERMINAL SEQUENCE; ANTIFUNGAL ACTIVITY; ANTIMICROBIAL ACTIVITY; AUTOCRINE EFFECT; BETA ADRENERGIC STIMULATION; CARDIOVASCULAR SYSTEM; CELL ADHESION; DISEASE MARKER; EXTRACELLULAR FLUID; GASTROINTESTINAL TRACT; HEART FAILURE; HOMEOSTASIS; HORMONE RELEASE; HORMONE SYNTHESIS; HUMAN; INNATE IMMUNITY; INOTROPISM; NONHUMAN; PARACRINE SIGNALING; PROTEIN DEGRADATION; PROTEIN FAMILY; PROTEIN FUNCTION; REGULATORY MECHANISM; REVIEW; SEQUENCE ANALYSIS; TUMOR; TUMOR DIAGNOSIS;

ANIMALIA; ANURA; INVERTEBRATA; MAMMALIA; RATTUS;

EID: 33947546012     PISSN: 10956433     EISSN: 15314332     Source Type: Journal    
DOI: 10.1016/j.cbpa.2006.05.016     Document Type: Review

References (64)

1. Aardal S., Helle K.B., Elsayed S., Reed R.K., and Serck-Hanssen G. Vasostatins, comprising the N-terminal domain of chromogranin A, suppress tension in isolated human blood vessel segments. J. Neuroendocrinol. 5 (1993) 405-412
2. Alloatti G., Gallo M.P., Levi R., Ramella R., and Tota B. Effects of Vasostatin 1 on calcium current and contractility in rat ventricular myocardium. International Workshop on Vasostatins and Chromogranin A-Derived Peptides", Capri, Italy, September 2005 (2006)
3. Amato A., Corti A., Serio R., and Mulè F. Inhibitory influence of chromogranin A N-terminal fragment (vasostatin-1) on the spontaneous contractions of rat proximal colon. Regul. Pept. 130 (2005) 42-47
4. Angeletti R.H., Aardal S., Serck-Hanssen G., Gee P., and Helle K.B. Vasoinhibitory activity of synthetic peptides from the amino terminus of chromogranin A. Acta Physiol. Scand. 152 (1994) 11-19
5. Angeletti R.H., Mints L., Aber C., and Russell J. Determination of residues in chromogranin A-(16-40) required for inhibition of parathyroid hormone secretion. Endocrinology 137 (1996) 2918-2922
6. Angeletti R.H., D'Amico T., and Russell J. Regulation of parathyroid secretion. Chromogranins, chemokines, and calcium. Adv. Exp. Med. Biol. 482 (2000) 217-223
7. Angelone T., Corti A., Pagliaro P., Losano G., Quintieri A.M., Tota B., and Cerra M.C. Vasostatins as modulators of cardiac performance in the isolated perfused rat Langendorff heart. International Workshop on Vasostatins and Chromogranin A-Derived Peptides", Capri, Italy, September 2005 (2006)
8. Aunis D., and Metz-Boutigue M.H. Chromogranins: current concepts. Structural and functional aspects. Adv. Exp. Med. Biol. 482 (2000) 21-38
9. Banks P., and Helle K. The release of protein from the stimulated adrenal medulla. Biochem. J. 97 (1965) 40C-41C
10. Barkatullah S.C., Curry W.J., Johnston C.F., Hutton J.C., and Buchanan K.D. Ontogenetic expression of chromogranin A and its derived peptides, WE-14 and pancreastatin, in the rat neuroendocrine system. Histochem. Cell Biol. 107 (1997) 251-257
11. Blois, A., Serck-Hanssen, G., 2006, present volume. Effects of vasostatin I on arterial endothelial cells stimulated by inflammatory agents. International Workshop on Vasostatins and Chromogranin A-Derived Peptides", Capri, Italy, September 2005. doi:10.1016/j.cbpa.2006.12.017 (see abstract in this issue).
12. Blois A., Holmsen H., Martino G., Corti A., Metz-Boutigue M.H., and Helle K.B. Interactions of chromogranin A-derived vasostatins and monolayers of phosphatidylserine, phosphatidylcholine and phosphatidylethanolamine. Regul. Pept. 15 134 (2006) 30-37
13. Blois A., Srebro B., Mandalà M., Corti A., Helle K.B., and Serck-Hanssen G. The chromogranin A peptide vasostatin-I inhibits gap formation and signal transduction mediated by inflammatory agents in cultured bovine pulmonary and coronary arterial endothelial cells. Regul. Pept. 135 1-2 (2006) 78-84
14. Brekke J.F., Osol G.J., and Helle K.B. N-terminal chromogranin-derived peptides as dilators of bovine coronsry resistance arteries. Regul. Pept. 105 (2002) 93-100
15. Ceconi C., Ferrari R., Bachetti T., Opasich C., Volterrani M., Colombo B., Parrinello G., and Corti A. Chromogranin A in heart failure; a novel neurohumoral factor and a predictor for mortality. Eur. Heart J. 23 (2002) 967-974
16. Cerra M.C., De Iuri L., Angelone T., Corti A., and Tota B. Recombinant N-terminal fragments of chromogranin-A modulate cardiac function of the Langendorff-perfused rat heart. Basic Res. Cardiol. 100 (2005) 1-10
17. Corti A., and Ferrero E. Chromogranin A in tumors: more than a marker for diagnosis and prognosis. Current Med. Chem. - Immunol., Endoc. Metab. Agents 4 (2004) 161-168
18. Corti A., Mannarino C., Mazza R., Angelone T., Longhi R., and Tota B. Chromogranin A N-terminal fragments vasostatin-1 and the synthetic CGA 7-57 peptide act as cardiostatins on the isolated working frog heart. Gen. Comp. Endocrinol. 136 (2004) 217-224
19. Corti A., Pieroni M., Cimenti C., Angelone T., Tota B., Curnis F., Colombo B., Russo M.A., Maseri A., and Frustaci A. Chromogranin A in hypertrophic and dilated cardiomyopathies. International Workshop on Vasostatins and Chromogranin A-Derived Peptides", Capri, Italy, September 2005 (2006)
20. Deftos L.J., Bjornsson B.T., Burton D.W., O'Connor D.T., and Copp D.H. Chromogranin A is present in and released by fish endocrine tissue. Life Sci. 40 (1987) 2133-2136
21. Di Felice V., Corti A., Cappello F., Amelio D., Tota B., and Zummo G. Cell- extracellular matrix interaction: a putative non-conventional target of vasostatin-1. International Workshop on Vasostatins and Chromogranin A-Derived Peptides", Capri, Italy, September 2005 (2006)
22. Di Felice, V., Cappello, F., Montalbano, A., Ardizzone, N., Campanella, C., De Luca, A., Amelio, D., Tota, B., Corti, A., Zummo, G., in press. Human recombinant vasostatin 1 may interfere with cell-extracellular matrix interactions. In Signal Transduction Pathways as Therapeutic Targets. Ed. M. Diederich. Ann. N. Y. Acad. Sci.
23. Feron O., and Balligand J.L. Caveolins and the regulation of endothelial nitric oxide synthase in the heart. Cardiovasc. Res. 69 (2006) 788-797
24. Ferrero E., Scabini S., Magni E., Foglieni C., Belloni D., Colombo B., Curnis F., Villa A., Ferrero M.E., and Corti A. Chromogranin A protects vessels against tumor necrosis factor alpha-induced vascular leakage. FASEB J. 18 (2004) 554-556
25. Gasparri A., Sidoli A., Sanchez L.P., Longhi R., Siccardi A.G., Marchisio P.C., and Corti A. Chromogranin A fragments modulate cell adhesion. Identification and characterization of a pro-adhesive domain. J. Biol. Chem. 272 (1997) 20835-20843
26. Ghia J.E., Crenner F., Rohr S., Meyer C., Metz-Boutigue M.H., Aunis D., and Angel F. A role for chromogranin A (4-16), a vasostatin-derived peptide, on human colonic motility. An in vitro study. Regul. Pept. 121 (2004) 31-39
27. Glattard E., Angelone T., Strub J.M., Corti A., Aunis D., Tota B., Metz-Boutigue M.H., and Goumon Y. Characterization of Natural Vasostatin-Containing Peptides in Rat Heart. FEBS J. 273 14 (2006) 3311-33121
28. Goumon,Y., Glattard, F., Angelone, T., Tota, B., Aunis, D., Metz-Boutigue, M.-H., 2006-this volume. Structural characterization of vasostatin-containing peptides in rat heart. International Workshop on Vasostatins and Chromogranin A-Derived Peptides", Capri, Italy, September 2005. doi:10.1016/j.cbpa.2006.12.011 (see abstract in this issue).
29. Helle K.B. The granin family of uniquely acidic proteins of the diffuse neuroendocrine system: comparative and functional aspects. Biol. Rev. Camb. Philos. Soc. 79 (2004) 769-794
30. Helle, K.B., 2006, present volume. Vasostatins, multifunctional peptides with homeostatic potentials. International Workshop on Vasostatins and Chromogranin A-Derived Peptides", Capri, Italy, September 2005. doi:10.1016/j.cbpa.2006.12.006 (see abstract in this issue).
31. Helle K.B., and Aunis D. A physiological role for the granins as prohormones for homeostatically important regulatory peptides? A working hypothesis for future research. Adv. Exp. Med. Biol. 482 (2000) 389-397
32. Helle K.B., Serck-Hanssen G., and Aardal S. Functional aspects of the adrenal medullary chromogranins. Neurochem. Int. 22 (1993) 353-360
33. Helle K.B., Metz-Boutigue M.H., and Aunis D. Chromogranin A as a calcium-binding precursor for a multitude of regulatory peptides of the immune, endocrine and metabolic systems. Curr. Med. Chem. - Immunol., Endoc. Metab. Agents (2001) 119-140
34. Huttner W.B., Gerdes H.H., and Rosa P. The granin (chromogranin/secretogranin) family. Trends Biochem. Sci. 16 (1991) 27-30
35. Imbrogno S., Angelone T., Corti A., Adamo C., Helle K.B., and Tota B. Influence of vasostatins, the chromogranin A-derived peptides, on the working heart of the eel (Anguilla anguilla): negative inotropy and mechanism of action. Gen. Comp. Endocrinol. 139 (2004) 20-28
36. Lazure C., Paquet L., Litthauer D., Naude R.J., Oelofsen W., and Chretien M. The ostrich pituitary contains a major peptide homologous to mammalian chromogranin A(1-76). Peptides 11 (1990) 79-87
37. Lugardon K., Raffner R., Goumon Y., Corti A., Delmas A., Bulet P., Aunis D., and Metz-Boutigue M.H. Antibacterial and antifungal activities of vasostatin-1, the N-terminal fragment of chromogranin A. J. Biol. Chem. 275 (2000) 10745-10753
38. Lugardon K., Chasserot-Golaz S., Kieffer A.E., Maget-Dana R., Nullans G., Kieffer B., Aunis D., and Metz-Boutigue M.H. Structural and biological characterization of chromofungin, the antifungal chromogranin A-(47-66)-derived peptide. J. Biol. Chem. 276 (2001) 35875-35882
39. Mahata, S.K., Mahapatra, N.R., Vaingankar, S.M., Sinha Hikim, A.P., Mahata, M., Gu, Y., Kennedy, B.P., Ziegler, M.G., Ross Jr., J., O'Connor, D.T., 2006, present volume. Role of catestatin in the development of hypertension. International Workshop on Vasostatins and Chromogranin A-Derived Peptides", Capri, Italy, September 2005. doi:10.1016/j.cbpa.2006.12.007 (see abstract in this issue).
40. Mandalà M., Brekke J.F., Serck-Hanssen G., Metz-Boutigue M.H., and Helle K.B. Chromogranin A-derived peptides: interaction with the rat posterior cerebral artery. Regul. Pept. 124 (2005) 73-80
41. Mazza R., Corti A., Imbrogno S., Mannarino C., Adamo C., Quintieri A., Metz-Boutigue M.H., Aunis D., Helle K.B., and Tota B. Comparative aspects of cardio-inhibitory action of vasostatin 1 in eel and frog hearts. International Workshop on Vasostatins and Chromogranin A-Derived Peptides", Capri, Italy, September 2005 (2006)
42. Metz-Boutigue M.H., Garcia-Sablone P., Hogue-Angeletti R., and Aunis D. Intracellular and extracellular processing of chromogranin A. Determination of cleavage sites. Eur. J. Biochem. 217 (1993) 247-257
43. Metz-Boutigue M.H., Helle K.B., and Aunis D. The innate immunity: roles for new antifungal and antibacterial peptides secreted by chromaffin granules from the adrenal medulla. Curr. Med. Chem. - Immunol., Endoc. Metab. Agents 4 (2004) 169-177
44. Metz-Boutigue, M.-H., Zhang, D., Lavigne, T., Giron, P., Schneider, F., Aunis, D., 2006, present volume. The implication of chromogranin A and B during severe sepsis. International Workshop on Vasostatins and Chromogranin A-Derived Peptides", Capri, Italy, September 2005. doi:10.1016/j.cbpa.2006.12.008 (see abstract in this issue).
45. Mulè F., Amato A., Zizzo M.G., Corti A., and Serio R. Actions of vasostatins on gastrointestinal function in rodents. International Workshop on Vasostatins and Chromogranin A-Derived Peptides", Capri, Italy, September 2005 (2006)
46. O'Connor D.T., and Bernstein K.N. Radioimmunoassay of chromogranin A in plasma as a measure of exocytotic sympathoadrenal activity in normal subjects and patients with pheochromocytoma. N. Engl. J. Med. 311 (1984) 764-770
47. Pagliaro P., Cappello S., Rastaldo R., Penna C., Angelone T., Corti A., Tota B., and Losano G. Protection against ischemia/reperfusion injuries by vasostatin-1 in the isolated rat heart. Physiological Society Meeting (2005), University of Oxford, United Kingdom September
48. Pagliaro P., Cappello S., Rastaldo R., Penna C., Angelone T., Corti A., Tota B., and Losano G.A. Protection against ischemia/reperfusion injures by Vasostatin-1 in the isolated rat heart. International Workshop on Vasostatins and Chromogranin A-Derived Peptides", Capri, Italy, September 2005 (2006)
49. Parmer R.J., and Miles L.A. Targeting of tissue plasminogen activator to the regulated pathway of secretion. Trends Cardiovasc. Med. 8 (1998) 306-312
50. Peterson J.B., Nelson D.L., Ling E., and Angeletti R.H. Chromogranin A-like proteins in the secretory granules of a protozoan, Paramecium tetraurelia. J. Biol. Chem. 262 (1987) 17264-17267
51. Ratti S., Curnis F., Longhi R., Colombo B., Gasparri A., Magni F., Manera E., Metz-Boutigue M.H., and Corti A. Structure-activity relationships of chromogranin A in cell adhesion. Identification of an adhesion site for fibroblasts and smooth muscle cells. J. Biol. Chem. 275 (2000) 29257-29263
52. Reinecke M., Hoog A., Ostenson C.G., Efendic S., Grimelius L., and Falkmer S. Phylogenetic aspects of pancreastatin- and chromogranin-like immunoreactive cells in the gastro-entero-pancreatic neuroendocrine system of vertebrates. Gen. Comp. Endocrinol. 83 (1991) 167-182
53. Russell J., Gee P., Liu S.M., and Angeletti R.H. Inhibition of parathyroid hormone secretion by amino-terminal chromogranin peptides. Endocrinology 135 (1994) 337-342
54. Smart D., Shaw C., Curry W.J., Johnston C.F., Thim L., Halton D.W., and Buchanan K.D. The primary structure of TE-6: a novel neuropeptide from the nematode Ascaris suum. Biochem. Biophys. Res. Commun. 187 (1992) 1323-1329
55. Steiner H.J., Weiler R., Ludescher C., Schmid K.W., and Winkler H. Chromogranins A and B are co-localized with atrial natriuretic peptides in secretory granules of rat heart. J. Histochem. Cytochem. 38 (1990) 845-850
56. Strub J.M., Sorokine O., Van Dorsselaer A., Aunis D., and Metz-Boutigue M.H. Phosphorylation and O-glycosylation sites of bovine chromogranin A from adrenal medullary chromaffin granules and their relationship with biological activities. J. Biol. Chem. 272 (1997) 11928-11936
57. Stridsberg M., Janson ET., and Portela-Gomes G.M. Cellular localization of Chromogranins and processed products in the diffuse neuroendocrine system and related tumours. Curr. Med. Chem. - Immunol., Endoc. Metab. Agents 4 (2004) 149-160
58. Taupenot L., Harper K.L., and O'Connor D.T. The chromogranin-secretogranin family. N. Engl. J. Med. 348 (2003) 1134-1149
59. Tota B., Imbrogno I., Mannarino C., and Mazza R. Vasostatins and negative inotropy in vertebrate hearts. Curr. Med. Chem. - Immunol., Endoc. Metab. Agents 4 (2004) 195-201
60. Trandaburu T., Syed Ali S., and Trandaburu I. Granin proteins (chromogranin A and secretogranin II C23-3 and C26-3) in the endocrine pancreas of reptiles. Ann. Anat. 181 (1999) 489-494
61. Turquier V., Vaudry H., Jegou S., and Anouar Y. Frog chromogranin A messenger ribonucleic acid encodes three highly conserved peptides. Coordinate regulation of proopiomelanocortin and chromogranin A gene expression in the pars intermedia of the pituitary during background color adaptation. Endocrinology 144 (1999) 4104-4112
62. Winkler H., and Fischer-Colbrie R. The chromogranins A and B: the first 25 years and future perspectives. Neuroscience 49 (1992) 497-528
63. Yanaihara N., Nishikawa Y., Hoshino M., Mochizuki T., Iguchi K., Nagasawa S., Jun L., Futai Y., Kanno T., Yanaihara M., Murai M., and Yanaihara C. Evaluation of region-specific radioimmunoassays for rat and human chromogranin A: measurement of immunoreactivity in plasma, urine and saliva. In: Kanno T., Nakazato Y., and Kumakura K. (Eds). The Adrenal Cell, Hokkaido (1998), University Press, Sapporo, Japan 305-313
64. Yang H.W., Kutok J.L., Lee N.H., Piao H.Y., Fletcher C.D., Kanki J.P., and Look A.T. Targeted expression of human MYCN selectively causes pancreatic neuroendocrine tumors in transgenic zebrafish. Cancer Res. 64 (2004) 7256-7262